Six vs 12 Months of Trastuzumab With Docetaxel Following FEC as Adjuvant Treatment in N+ Breast Cancer
A phase 3 trial of Docetaxel, Trastuzumab, Epirubicin, Cyclophosphamide, Fluorouracil, Lenograstim and Pegfilgrastim in Breast cancer, run by Hellenic Oncology Research Group, completed.
Overview
Six vs 12 Months of Trastuzumab With Docetaxel Following FEC as Adjuvant Treatment in N+ Breast Cancer is a phase 3 interventional study registered as NCT00615602 by Hellenic Oncology Research Group, with 489 participants recorded, started 2004-10 and reaching its primary completion in 2012-05. Interventions recorded: Docetaxel, Trastuzumab, Epirubicin, Cyclophosphamide, 5-fluoruracil, Granulocyte-colony stimulating growth factor, Trastuzumab. Conditions recorded: Breast Cancer.
Linked to the drug Lenograstim because the registry names it among its interventions and Breast cancer among its conditions. Registry record only: no result has been read by an editor.
Similar pages
not linked directly; found by shared links- TrialSequential Administration of FE75C and Docetaxel Versus Docetaxel/Cyclophosphamide in HER-2 Negative, Node Positive Breast Cancer
Shares Lenograstim, Pegfilgrastim, Epirubicin, Fluorouracil (5-FU) and the tag pipeline.
- TrialRandomized Phase III Trial Comparing Sequential Administration of FE75C Followed by Docetaxel Versus Paclitaxel as Adjuvant Chemotherapy in Axillary Lymph Node (+) Breast Cancer
Shares Lenograstim, Pegfilgrastim, Epirubicin, Fluorouracil (5-FU) and the tag pipeline.
- TrialSafety and Efficacy Comparison of Docetaxel and Ixabepilone in Non Metastatic Poor Prognosis Breast Cancer
Shares Epirubicin, Fluorouracil (5-FU), Docetaxel, Breast cancer (all types) and the tag pipeline.
- TrialChemotherapy With or Without Trastuzumab After Surgery in Treating Women With Invasive Breast Cancer
Shares Docetaxel, Breast cancer (all types), Cyclophosphamide, Trastuzumab and the tag pipeline.
- TrialACCELERATE: Doxorubicin and Cyclophosphamide Followed by Paclitaxel With Pegfilgrastim and Darbepoetin Alfa Support for the Treatment of Women With Breast Cancer
Shares Pegfilgrastim, Breast cancer (all types) and the tag pipeline.
- TrialPrecise Chemoresection in Low-grade NMIBC Using Drug Screens in Patient-derived Organoids
Shares Epirubicin, Docetaxel and the tag pipeline.
- TrialCombination Chemotherapy, Surgery, and Radiation Therapy With or Without Dexrazoxane and Trastuzumab in Treating Women With Stage III or Stage IV Breast Cancer
Shares Breast cancer (all types), Cyclophosphamide, Trastuzumab and the tag pipeline.
- TrialDocetaxel and Cisplatin With or Without Dimesna in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer
Shares Pegfilgrastim, Docetaxel and the tag pipeline.